We are live on ! Find out more
BC

BIT Capital Portfolio holdings

AUM $3.38B
1-Year Est. Return 214.12%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+214.12%
3 Year Est. Return
+1,162.23%
5 Year Est. Return
+1,566.59%
10 Year Est. Return
AUM
$2.72B
AUM Growth
-$204M
Cap. Flow
+$228M
Cap. Flow %
8.38%
Top 10 Hldgs %
52.84%
Holding
145
New
35
Increased
38
Reduced
29
Closed
41

Top Sells

Rank Stock Value
1
HIMS icon
Hims & Hers Health
HIMS
+$78.6M
2
BABA icon
Alibaba
BABA
+$72.9M
3
BMNR
BitMine Immersion Technologies
BMNR
+$58.3M
4
CVNA icon
Carvana
CVNA
+$54.4M
5
RDDT icon
Reddit
RDDT
+$43.4M

Sector Composition

Rank Sector Weight
1 Technology 32.2%
2 Financials 24.81%
3 Miscellaneous 15.6%
4 Communication Services 13.66%
5 Healthcare 10.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOFI icon
101
SoFi Technologies
SOFI
$23.5B
$44.3K ﹤0.01%
1,693
-40,138
-96% -$1.12M
GTM
102
ZoomInfo Technologies
GTM
$1.2B
$20.4K ﹤0.01%
2,005
-26,663
-93% -$275K
ISRG icon
103
Intuitive Surgical
ISRG
$130B
$19.8K ﹤0.01%
35
-715
-95% -$381K
GRND icon
104
CALL
Grindr
GRND
$2.65B
$10.8K ﹤0.01%
+800
New +$10.9K
AGIO icon
105
Agios Pharmaceuticals
AGIO
$1.98B
-1,571
Closed -$63.1K
AKRO
106
DELISTED
Akero Therapeutics
AKRO
-1,261
Closed -$59.9K
AMD icon
107
CALL
Advanced Micro Devices
AMD
$780B
-40,000
Closed -$6.47M
APLD icon
108
PUT
Applied Digital
APLD
$7.5B
-600,000
Closed -$13.8M
ARGX icon
109
argenx
ARGX
$64.6B
-50
Closed -$36.9K
ATAI icon
110
AtaiBeckley Inc
ATAI
$2.74B
-12,501
Closed -$66.1K
AVTX icon
111
Avalo Therapeutics
AVTX
$1.03B
-1,929
Closed -$24.5K
BBIO icon
112
BridgeBio Pharma
BBIO
$14.6B
-1,056
Closed -$54.8K
BEAM icon
113
Beam Therapeutics
BEAM
$3.06B
-3,390
Closed -$82.3K
BTDR icon
114
CALL
Bitdeer Technologies
BTDR
$3.36B
-230,000
Closed -$3.93M
BNC
115
CEA Industries
BNC
$144M
-467,067
Closed -$3.64M
CLSK icon
116
CALL
CleanSpark
CLSK
$3.26B
-280,000
Closed -$4.06M
CORZ icon
117
Core Scientific
CORZ
$5.75B
-250,353
Closed -$4.37M
CTMX icon
118
CytomX Therapeutics
CTMX
$808M
-16,285
Closed -$51.9K
CYTK icon
119
Cytokinetics
CYTK
$10.1B
-1,254
Closed -$68.9K
ELVN icon
120
Enliven Therapeutics
ELVN
$4.35B
-3,181
Closed -$65.1K
FULC icon
121
Fulcrum Therapeutics
FULC
$294M
-6,090
Closed -$56K
GOOG icon
122
CALL
Alphabet (Google) Class C
GOOG
$4.1T
-253,700
Closed -$61.8M
GOOGL icon
123
CALL
Alphabet (Google) Class A
GOOGL
$4.14T
-261,700
Closed -$63.6M
HEPS
124
D-Market Electronic Services & Trading
HEPS
$954M
-1,538,011
Closed -$4.14M
IMCR icon
125
Immunocore
IMCR
$1.86B
-1,771
Closed -$64.3K

Similar funds

BIT Capital's Q4 2025 Portfolio in Review

As of Q4 2025, BIT Capital held 145 positions worth $2.72B, down 7% from $2.92B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

BIT Capital deployed $228M of net new capital in Q4 2025, opening 35 new positions and adding to 38 existing holdings. Its largest new stake was Alphabet (Google) Class A: 457,908 shares worth $143M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 25% a quarter earlier, followed by Financials and Miscellaneous.

On the sell side, the largest reduction was Hims & Hers Health, an estimated $78.6M trimmed.

  • BIT Capital's largest Q4 2025 buy was Alphabet (Google) Class A: 457,908 shares worth $143M.
  • BIT Capital added most to Oscar Health in Q4 2025, an estimated $90.4M increase.
  • BIT Capital's biggest Q4 2025 reduction was Hims & Hers Health, cutting an estimated $78.6M.
  • BIT Capital fully exited Sharplink Inc in Q4 2025, selling an estimated $20.7M.
  • BIT Capital's ten largest holdings make up 53% of its $2.72B portfolio in Q4 2025.
  • BIT Capital opened 35 new positions and closed 41 in Q4 2025.
  • BIT Capital's portfolio value fell 7% quarter-over-quarter to $2.72B.

Based on BIT Capital's 13F filing for Q4 2025, filed 11 Feb 2026.